Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Revenue (2020 - 2026)

NeuroPace has reported Revenue over the past 7 years, most recently at $22.1 million for Q1 2026.

  • For Q1 2026, Revenue fell 2.02% year-over-year to $22.1 million; the TTM value through Mar 2026 reached $99.5 million, up 18.06%, while the annual FY2025 figure was $100.0 million, 25.13% up from the prior year.
  • Revenue for Q1 2026 was $22.1 million at NeuroPace, down from $26.6 million in the prior quarter.
  • Over five years, Revenue peaked at $27.4 million in Q3 2025 and troughed at $10.2 million in Q2 2022.
  • A 5-year average of $18.4 million and a median of $18.1 million in 2024 define the central range for Revenue.
  • Biggest five-year swings in Revenue: decreased 19.24% in 2022 and later skyrocketed 61.86% in 2023.
  • Year by year, Revenue stood at $12.8 million in 2022, then soared by 40.84% to $18.0 million in 2023, then grew by 19.18% to $21.5 million in 2024, then increased by 23.86% to $26.6 million in 2025, then dropped by 17.0% to $22.1 million in 2026.
  • Business Quant data shows Revenue for NPCE at $22.1 million in Q1 2026, $26.6 million in Q4 2025, and $27.4 million in Q3 2025.